Zacks Investment Research upgraded shares of Bicycle Therapeutics (NASDAQ:BCYC) from a sell rating to a hold rating in a report released on Friday, Zacks.com reports. According to Zacks, “Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are […]
NASDAQBCYC
Bicycle Therapeutics (NASDAQ:BCYC) Stock Rating Upgraded by BidaskClub
Bicycle Therapeutics (NASDAQ:BCYC) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, BidAskClub reports. A number of other equities research analysts have also recently weighed in on BCYC. Cantor Fitzgerald started coverage on Bicycle Therapeutics in a research note […]
Analysts Set Bicycle Therapeutics Limited (NASDAQ:BCYC) PT at $24.80
Bicycle Therapeutics Limited (NASDAQ:BCYC) has been given a consensus recommendation of “Buy” by the eight analysts that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have given a buy recommendation to the company. […]